Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
City Therapeutics, a clinical-stage biotechnology company developing RNA interference (RNAi) medicines, filed an S-1 to go public on the Nasdaq Global Market under the ticker CTY. The IPO is led by Goldman Sachs, Jefferies, Stifel and Oppenheimer. Proceeds will fund clinical trials for its lead pro…
Drug developer City Therapeutics filed for an initial public offering in the US on Thursday.The Cambridge, Massachusetts-based company plans to sell new shares in the IPO.City Therapeutics will list on the Nasdaq under the symbol “CTY.”Goldman Sachs, Jefferies, Stifel and Oppenheimer are the unde…
City Therapeutics Files for IPO
Drug developer City Therapeutics filed for an initial public offering in the US on Thursday.